歌礼制药-B(01672.HK) 公布,董事会认为公司现时股价被低估,已决议将股份购回资金由最多3亿元增至最多5亿元。集团指,股份现时的成交价未能反映其内在价值。董事会相信,经更新建议股份购回可提升股份的价值,从而提高股东的回报。此外,董事会相信,经更新建议股份购回反映公司对自身的长远业务前景及增长潜力充满信心,且最终将可惠及公司,并符合公司及股东整体的最佳利益。于12月15日,公司已根据此次购回...
Source Link歌礼制药-B(01672.HK) 公布,董事会认为公司现时股价被低估,已决议将股份购回资金由最多3亿元增至最多5亿元。集团指,股份现时的成交价未能反映其内在价值。董事会相信,经更新建议股份购回可提升股份的价值,从而提高股东的回报。此外,董事会相信,经更新建议股份购回反映公司对自身的长远业务前景及增长潜力充满信心,且最终将可惠及公司,并符合公司及股东整体的最佳利益。于12月15日,公司已根据此次购回...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.